These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37952931)

  • 1. Assessment of health-related quality of life in patients with Chagas cardiomyopathy using Minnesota living with heart failure questionnaire: A validation study.
    Trindade AFV; Silva WT; Lima VP; Mendonça VA; Lacerda ACR; Ávila MR; de Oliveira LFF; de Almeida ILGI; Silva KLS; de Oliveira LFL; Carvalho LMS; da Cruz Ferreira PH; de Faria SCC; Mediano MFF; Figueiredo PHS; Costa HS
    Trop Med Int Health; 2024 Jan; 29(1):6-12. PubMed ID: 37952931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function.
    Silva WT; Ávila MR; Oliveira LFF; Figueiredo PHS; Lima VP; Bastone AC; Costa FSMD; Mediano MFF; Costa HS; Rocha MODC
    Rev Soc Bras Med Trop; 2020; 53():e20200123. PubMed ID: 33174953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of baseline parameters on one-year physical, mental, and health-related quality of life in patients with heart failure and preserved ejection fraction.
    Fitz J; Edelmann F; Hasenfuß G; Sandek A; Nolte K; Hashemi D; Trippel TD; Wachter R; Herrmann-Lingen C
    ESC Heart Fail; 2021 Dec; 8(6):4635-4643. PubMed ID: 34480783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of health-related quality of life in identifying systolic dysfunction in patients with Chagas cardiomyopathy.
    Ávila MR; Figueiredo PHS; Lima VP; Silva WT; Vianna MVA; Fernandes LHC; de Azevedo ACA; Lima MMO; de Carvalho Bastone A; do Carmo Pereira Nunes M; Mediano MFF; da Costa Rocha MO; Costa HS
    Trop Med Int Health; 2021 Aug; 26(8):936-942. PubMed ID: 33864407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial.
    Nolte K; Herrmann-Lingen C; Wachter R; Gelbrich G; Düngen HD; Duvinage A; Hoischen N; von Oehsen K; Schwarz S; Hasenfuss G; Halle M; Pieske B; Edelmann F
    Eur J Prev Cardiol; 2015 May; 22(5):582-93. PubMed ID: 24627449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Health-Related Quality of Life in Outpatients with Chagas and Matched Non-Chagas Chronic Heart Failure in Colombia: A Cross-Sectional Analysis.
    Olivera MJ; Fory JA; Buitrago G
    Am J Trop Med Hyg; 2021 Feb; 104(3):951-958. PubMed ID: 33534736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.
    Martí-Carvajal AJ; Kwong JS
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009077. PubMed ID: 27388039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study.
    Zachariah D; Stevens D; Sidorowicz G; Spooner C; Rowell N; Taylor J; Kay R; Salek MS; Kalra PR;
    Int J Cardiol; 2017 Dec; 249():313-318. PubMed ID: 29121732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of functional performance in Chagas heart disease by Human Activity Profile questionnaire.
    Costa HS; Lima MMO; Vieira CFD; Silva WT; Nunes MDCP; Rocha MOC; Lima VP; Lacerda ACR; Mendonça VA; Figueiredo PHS
    Disabil Rehabil; 2021 May; 43(9):1255-1259. PubMed ID: 31422702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the Minnesota Living With Heart Failure Questionnaire and key ventilatory expired gas measures during exercise testing in patients with heart failure.
    Arena R; Humphrey R; Peberdy MA
    J Cardiopulm Rehabil; 2002; 22(4):273-7. PubMed ID: 12202848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Functional Capacity in Chagas Heart Disease by Incremental Shuttle Walk Test and its Relation to Quality-of-Life.
    Costa HS; Alves RL; da Silva SA; Alencar MC; Nunes Mdo C; Lima MM; Rocha MO
    Int J Prev Med; 2014 Feb; 5(2):152-8. PubMed ID: 24627740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of health-related quality of life in patients with Chagas heart disease.
    Costa HS; Lima MMO; Figueiredo PHS; Chaves AT; Nunes MCP; da Costa Rocha MO
    Qual Life Res; 2019 Jan; 28(1):67-72. PubMed ID: 30167935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in patients with Chagas disease.
    Oliveira BG; Abreu MN; Abreu CD; Rocha MO; Ribeiro AL
    Rev Soc Bras Med Trop; 2011; 44(2):150-6. PubMed ID: 21556489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure survival score in patients with Chagas disease: correlation with functional variables.
    Ritt LE; Carvalho AC; Feitosa GS; Pinho-Filho JA; Macedo CR; Vilas-Boas F; Andrade MV; Feitosa-Filho GS; Almeida AJ; Barojas M; Lopes RD
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):538-43. PubMed ID: 22513344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.
    Capota R; Militaru S; Ionescu AA; Rosca M; Baicus C; Popescu BA; Jurcut R
    Health Qual Life Outcomes; 2020 Oct; 18(1):351. PubMed ID: 33126893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with heart failure and improved ejection fraction: one-year changes and prognosis.
    Zamora E; González B; Lupón J; Borrellas A; Domingo M; Santiago-Vacas E; Cediel G; Codina P; Rivas C; Pulido A; Crespo E; Velayos P; Diaz V; Bayes-Genis A
    ESC Heart Fail; 2022 Dec; 9(6):3804-3813. PubMed ID: 35916351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utility of the Minnesota Living With Heart Failure Questionnaire for assessing quality of life in heart failure patients].
    Morcillo C; Aguado O; Delás J; Rosell F
    Rev Esp Cardiol; 2007 Oct; 60(10):1093-6. PubMed ID: 17953932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between variables of cardiopulmonary exercise test and quality of life in patients with chronic Chagas cardiomyopathy (Insights from the PEACH STUDY).
    Vieira MC; Mendes FSNS; Silva PSD; Silva GMSD; Mazzoli-Rocha F; Sousa AS; Saraiva RM; Quintana MSB; Costa HS; Paravidino VB; Rodrigues LF; Hasslocher-Moreno AM; Americano do Brasil PEA; Mediano MFF
    PLoS One; 2022; 17(12):e0279086. PubMed ID: 36520825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPAIRED QUALITY OF LIFE IN CHAGAS ACALASIA PATIENTS AND ASSOCIATED CLINICAL FACTORS.
    Rosa-E-Silva L; Pontes RMA; Vendrame GLME; Xavier FAL; Kreling GAD; Bellinati PQ
    Arq Gastroenterol; 2022; 59(2):281-287. PubMed ID: 35830042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the Incremental Shuttle Walk Test in Chagas cardiomyopathy.
    Ávila MR; Figueiredo PHS; Lima VP; de Oliveira LFL; de Oliveira LFF; Silva WT; Trede Filho RG; de Carvalho Bastone A; Lacerda ACR; Mendonça VA; Mediano MFF; Costa HS
    Disabil Rehabil; 2022 Dec; 44(24):7516-7521. PubMed ID: 34613873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.